DR. PETER MARTIN THULE, MD
Osteopathic Medicine at Clairmont Rd, Decatur, GA
License number
Georgia 33727
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
2
1670 Clairmont Rd, Decatur, GA 30033
3981 Bonnington Ct, Atlanta, GA 30341
3981 Bonnington Ct, Atlanta, GA 30341
Phone
(404) 321-6111
(404) 235-3011 (Fax)
(770) 455-7244
(404) 235-3011 (Fax)
(770) 455-7244
Personal information
See more information about PETER MARTIN THULE at radaris.comName
Address
Phone
3981 Bonnington Ct, Chamblee, GA 30341
Professional information
See more information about PETER MARTIN THULE at trustoria.com
Dr. Peter M Thule, Decatur GA - MD (Doctor of Medicine)
Dr. Peter M Thule, Decatur GA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
Atlanta VA Med Ctr Endcrnlgy
1670 Clairmont Rd, Decatur 30033
(404) 321-6111 (Phone)
1670 Clairmont Rd, Decatur 30033
(404) 321-6111 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1995, Internal Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Justus-Liebig University / College of Human Medicine
Justus-Liebig University / College of Human Medicine
Peter Thule, Decatur GA
Peter Thule, Decatur GA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Adult Medicine
Work:
Atlanta Va Medical Center
1670 Clairmont Rd, Decatur, GA 30033
1670 Clairmont Rd, Decatur, GA 30033
Education:
(1986)
Glucose Sensitive Regulator Of Insulin Transcription
Glucose Sensitive Regulator Of Insulin Transcription
US Patent:
2002010, Aug 8, 2002
Filed:
Oct 10, 2001
Appl. No.:
09/972916
Inventors:
Peter Thule - Atlanta GA, US
International Classification:
A61K048/00, C07H021/04
US Classification:
514/012000, 514/044000, 536/023200
Abstract:
A glucose sensitive regulator of insulin transcription includes a glucose response element (GIRE) of a liver-pyruvate (L-PK) gent promoter, and an insulin-sensitive element of an insulin-like growth factor binding protein-1 (IGFBP-1) basal promoter. The transcriptional activity of the regulator is stimulated by glucose and inhibited by insulin.